Launch your talent and have an impact on our mission to help patients around the world with severe and chronic diseases lead better, healthier lives!
Vifor Pharma is offering you the great opportunity to participate in our 2 year Graduate Program within Technical Operations, where you will get an insight into 4 different departments at 2 different sites (St. Gallen and Lisbon).
The earliest start is between January and March 2021.
This exciting program includes the following:
Rotating assignments in key functions within Technical Operations: Supply Chain Management, Manufacturing/ Production, Quality Assurance (QA)/ Quality Control (QC), Technical Project Management
Cooperation at different locations
The opportunity to interact with various functions and sites
Regular mentoring sessions with your sponsor
Opportunity to join us for an unlimited contract in a first Managerial role after successful completion of the Graduate Program
For this responsible position, you should bring the following profile:
Graduate (BSc/ MSc/ PhD) in Life Sciences (e.g. pharmaceutical studies, biology, chemistry, preferably bioengineering)
First insight into the industry (e.g. during internships in pharma industry), but max. 2 years of experience (incl. internships)
Fluency in English (oral and written)
Fluency in German OR French, good knowledge of the other language
You have a high learning capability and the ability to think outside the box, linking ideas and concepts. You are an excellent team player with very good communication skills as well as very good organisation and planning skills. With this opportunity you can apply your theoretical knowledge and gain first practical experience in different areas of a rapidly growing, global pharmaceutical company.
A propos de nous
Le Groupe Vifor Pharma est une entreprise pharmaceutique internationale. Il occupe une position de leader dans toutes ses activités clés et se compose des entreprises suivantes: Vifor Pharma et Vifor Fresenius Medical Care Renal Pharma (sa société commune avec Fresenius Medical Care). Le Groupe Vifor Pharma est coté à la Bourse suisse (SIX Swiss Exchange, VIFN, ISIN: CH0364749348.